Download Biomarker group Name Presence Reference Immune system

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts
no text concepts found
Transcript
Biomarker group
Immune system alteration
Cytokines
Chemokines and their receptors
Myelin Antibodies
Complement-related biomarkers
Cell-cycle and apoptosis markers
Cerebrospinal Fluid oligoclonal bands
Blood-brain barrier damage
Astrocytic protein
Matrix Metalloproteases /their inhibitors
Integral proteins
Name
IL-1, IL-2 ,,IL-6, TNF-a, TGF-β
CCR5 , CC2/CCL2
anti-myelin-basic protein a-MBP
anti-MOG antibody
C3 , C4 activated neo-C9
FAS, FAS-L, BCL-2, TRAIL
Presence
Reference
Peripheral blood
Peripheral blood
CSF
CSF
Peripheral blood
(1, 2)
(3, 4)
(1)
CSF
(3)
S100β
MMP , TIMP
Thrombomodulin
CSF
CSF
CSF
(4)
(1)
Calpain, Pepsin
MBP-gliotoxin , QYNAD
Peripheral blood
CSF
(1)
Nitric Oxide and their stable metabolites
NO NO2, NO3
CSF and
Peripheral blood
Neuronal damage
Cytoskeleton and microtubule-associated
proteins
Biomarkers of gliosis
TAU protein Actin Tubulin
CSF
GFAP
CACY, CAPL, S100L//β
CSF and
Peripheral blood
CSF
NCAM
CPK-BB
NSE
CSF
CSF
CSF
Demyelination
Proteolytic enzymes
Gliotoxins
Markers of oxidative stress
Glial Fibrillary Acidic Protein
S100 proteins
Remyelination and repair
Neural cell adhesive molecules
Creatinine Phosphokine izoenzymes
neural-specific enolase
(5)
(1)
(1)
(2, 5)
(1)
Supplementary Table 1. MS biomarkers.
References
1.
2.
3.
4.
5.
6.
Bielekova B & Martin R (2004) Development of biomarkers in multiple
sclerosis Brain 127, 1463-1478.
Lassmann H & Ransohoff RM (2004) The CD4-Th1 model for multiple
sclerosis: a critical [correction of crucial] re-appraisal Trends Immunol 25,
132-137.
Williams KC, Ulvestad E, & Hickey WF (1994) Immunology of multiple
sclerosis Clin Neurosci 2, 229-245.
Marchi N, Cavaglia M, Fazio V, Bhudia S, Hallene K, et al. (2004) Peripheral
markers of blood-brain barrier damage Clin Chim Acta 342, 1-12.
Giovannoni G, Miller DH, Losseff NA, Sailer M, Lewellyn-Smith N, et al.
(2001) Serum inflammatory markers and clinical/MRI markers of disease
progression in multiple sclerosis J Neurol 248, 487-495.
H.H. Roenigh & Maibach HI (1985) Psoriasis ( Marcel Dekker, New York,
Basel).
Related documents